Comparison between huperzine A, tacrine, and E2020 on cholinergic transmission at mouse neuromuscular junction in vitro

Acta Pharmacologica Sinica

Volumn 18, Issue 1, 1997, Pages 6-10

  Lin, Jia Hui ^a   Hu, Guo Yuan ^a   Tang, Xi Can ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

cholinesterase inhibitors; diaphragm; E2020; electrophysiology; huperzine A; neuromuscular junction; phrenic nerve; tacrine

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; HUPERZINE A; TACRINE;

ANIMAL TISSUE; ARTICLE; CHOLINERGIC TRANSMISSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDPLATE POTENTIAL; FEMALE; HEMIDIAPHRAGM; INTRACELLULAR RECORDING; MALE; MINIATURE ENDPLATE POTENTIAL; MOUSE; MUSCLE FIBER MEMBRANE STEADY POTENTIAL; NEUROMUSCULAR SYNAPSE; NONHUMAN; PHRENIC NERVE;

ACTION POTENTIALS; ANIMALS; CHOLINESTERASE INHIBITORS; FEMALE; INDANS; MALE; MEMBRANE POTENTIALS; MICE; MUSCLE FIBERS; MUSCLE FIBERS, SKELETAL; NEUROMUSCULAR JUNCTION; PHRENIC NERVE; PIPERIDINES; SESQUITERPENES; TACRINE;

EID: 0031026826     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ames DJ, Bhathal PS, Davies BM, Fraser JRE. Hepatotoxicity of tetrahydroacridine. Lancet 1988; I: 887.
2. Rogers SL, Yamanishi Y, Yamatsu K. E2020 - the pharmacology of a piperidine cholinesterase inhibitor. In: Becker R, Giacobini E, editors. Cholinergic basis for Alzheimer therapy. Boston: Birkhäuser, 1991: 314-20.
3. Tang XC, DeSarno P, Sugaya K, Giacobini E. Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat. J Neurosci Res 1989; 24: 276-85.
4. Tang XC, Xiong ZQ, Qian BC, Zhou ZF, Zhang CL. Cognition improvement by oral huperzine A: a novel acetylcholinesterase inhibitor. In: Giacobini E, Becker R, editors. Alzheimer disease: therapeutic strategies. Boston: Birkhaüser, 1994: 113-9.
5. Xu SS, Gao ZX, Weng Z, Du ZM, Xu WA, Yang JS, et al. Efficacy of tablet huperzine A on memory, cognition, and behavior in Alzheimer's disease. Acta Pharmacol Sin 1995; 16: 391-5.
6. Schauf CL, Sattin A. Tetrahydroaminoacridine blocks potassium channels and inhibits sodium inactivation in Myxicola . J Pharmacol Exp Ther 1987; 243: 609-13.
7. Shi YL, Xu YF, Wang WP, Xu K, Guo M, Wang KY. Facilitatory effect of Pinellia ternata lectin on quantal release of acetylcholine from nerve terminals. Acta Pharmacol Sin 1992; 13: 513-6.
8. Van der Kloot W. The regulation of quantal size. Prog Neurobiol 1991; 36: 93-130.
9. Fiekers JF. Interactions of edrophonium, physostigmine and methanesulfonyl fluoride with the snake end-plate acetylcholine receptor-channel complex. J Pharmacol Exp Ther 1985; 234: 539-49.
10. Lin JH, Hu GY, Tang XC. Facilitatory effect of huperzine A on mouse neuromuscular transmission in vitro. Acta Pharmacol Sin 1996; 17: 299-301.
11. Laganière S, Corey J, Tang XC, WÜlfert E, Hanin I. Acute and chronic studies with the anticholinesterase huperzine A: effect on central nervous system cholinergic parameters. Neuropharmacology 1991; 30: 763-8.
12. Zhang GB, Wang MY, Zheng JQ, Tang XC. Facilitation of cholinergic transmission by huperzine A in toad paravertebral. ganglia in vitro. Acta Pharmacol Sin 1994; 15: 158-61.
13. Braga MFM, Harvey AL, Rowan EG. Effects of tacrine, velnacrine (HP029), suronacrine (HP128), and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro. Br J Pharmacol 1991; 102: 909-15.
14. Canti C, Marti E, Marsal J, Solsona C. Tacrine-induced increase in the release of spontaneous high quantal content events in Torpedo electric organ. Br J Pharmacol 1994; 112: 19-22.
15. Stevens CF. Quantal release of neurotransmitter and long-term potentiation. Cell 1993; 72 Suppl: 55-63.